| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/23/1995 | WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 02/23/1995 | WO1995005460A2 Feline immunodeficiency virus isolate ncsu 1 |
| 02/23/1995 | WO1995005459A1 Genes determining cellular senescence in yeast |
| 02/23/1995 | WO1995005456A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 02/23/1995 | WO1995005455A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 02/23/1995 | WO1995005454A1 Engineered bacteriophages and vaccines containing them |
| 02/23/1995 | WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 02/23/1995 | WO1995005400A1 Heparin functional affinity supports |
| 02/23/1995 | WO1995005397A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | WO1995005396A1 Transglutaminase cross-linkable polypeptides and methods relating thereto |
| 02/23/1995 | WO1995005395A1 Method of diagnosing alzheimer's disease |
| 02/23/1995 | WO1995005394A1 Therapeutic and diagnostic agents for amyloidosis |
| 02/23/1995 | WO1995005393A2 Lipopolysaccharide-binding and neutralizing peptides |
| 02/23/1995 | WO1995005392A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences |
| 02/23/1995 | WO1995005201A1 Adenoviruses having modified fiber proteins |
| 02/23/1995 | WO1995005194A1 Vaccine compositions |
| 02/23/1995 | WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY |
| 02/23/1995 | WO1995005190A1 Method of inhibiting kaposi's sarcoma |
| 02/23/1995 | WO1995005189A1 Class i mhc modulation of surface receptor activity |
| 02/23/1995 | WO1995005187A1 Hepatoselective pharmaceutical actives |
| 02/23/1995 | DE4407538C1 Binding reagent for cell surface protein and effector cell |
| 02/23/1995 | DE4328336A1 Thrombin inhibitor from the saliva of protostomes |
| 02/23/1995 | DE4320677A1 Synthetic peptides for neutralising the infectiosity of the AIDS VIRUS (HIV) |
| 02/23/1995 | CA2169837A1 Compositions and methods for detecting target nucleic acid sequences utilizing adjacent sequence-enzyme molecules |
| 02/23/1995 | CA2169833A1 Chitinase, dna coding therefor and plants containing same |
| 02/23/1995 | CA2169459A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences |
| 02/23/1995 | CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity |
| 02/23/1995 | CA2169285A1 Class i mhc modulation of surface receptor activity |
| 02/23/1995 | CA2169178A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | CA2168038A1 Heparin functional affinity supports |
| 02/23/1995 | CA2167942A1 Method of inhibiting kaposi's sarcoma |
| 02/23/1995 | CA2146667A1 Lipopolysaccharide-binding and neutralizing peptides |
| 02/22/1995 | EP0639643A2 Mutant AOX2 promoter |
| 02/22/1995 | EP0639642A1 Chitinase, DNA coding therefore and plants containing same |
| 02/22/1995 | EP0639607A2 Method and apparatus for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| 02/22/1995 | EP0639584A1 Preparation and screening of highly diverse peptide libraries for binding activity |
| 02/22/1995 | EP0639582A2 Polynucleotide assay reagent and method |
| 02/22/1995 | EP0639230A1 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum |
| 02/22/1995 | EP0639226A1 Rna molecule for use in treating leukemias |
| 02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 02/22/1995 | EP0639224A1 Lectin domain variants of selectin |
| 02/22/1995 | EP0639203A1 Factor viii purification process |
| 02/22/1995 | EP0639202A1 Stable polypeptide composition |
| 02/22/1995 | EP0639083A1 Complexing agents and targeting immunoreagents |
| 02/22/1995 | EP0619732A4 Biodegradable polymers for cell transplantation. |
| 02/22/1995 | EP0535060B1 Antifungal polypeptide, process for producing it |
| 02/22/1995 | EP0478659B1 Interferon purification process |
| 02/22/1995 | EP0438401B1 Combination lock for blood identification system |
| 02/22/1995 | EP0319570B1 Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 02/22/1995 | EP0229829B1 Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
| 02/22/1995 | CN1099040A Linear adhesion inhibitor |
| 02/22/1995 | CN1098942A Treatment of juvenile diabetes |
| 02/21/1995 | US5391715 Contacting with a hydroxyapatite adsorbent; apolar-ligand chromatography |
| 02/21/1995 | US5391714 Polymorphism of human platelet membrane glycoprotein IIIA and diagnostic applications thereof |
| 02/21/1995 | US5391713 Interferon purification process |
| 02/21/1995 | US5391712 Non-hemolytic streptolysin O variants |
| 02/21/1995 | US5391711 Biotinylating reagent and purification process for synthesized peptide using thereof |
| 02/21/1995 | US5391706 Purification of GM-CSF |
| 02/21/1995 | US5391704 A labeled polypeptides used to detect and determine anti-immunoglobulins autoantibodies in autoimmune diseases |
| 02/21/1995 | US5391497 Human k-casein |
| 02/21/1995 | US5391490 Ubiquitin-specific protease |
| 02/21/1995 | US5391485 DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| 02/21/1995 | US5391483 Using mixture of periodic acid and chromium trioxide |
| 02/21/1995 | US5391380 Used in blood coagulation tests; mixed with metal ion chelator |
| 02/21/1995 | CA1334513C Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 02/20/1995 | CA2130125A1 Use of amylin in pharmaceutical screens |
| 02/17/1995 | CA2104142A1 Dna molecule encoding freezing tolerance proteins in gramineae |
| 02/16/1995 | WO1995004932A1 Quantitation of carbohydrate deficient transferrin in high alcohol consumption by hplc |
| 02/16/1995 | WO1995004843A1 Surface coating method |
| 02/16/1995 | WO1995004829A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | WO1995004827A1 Tick antigen |
| 02/16/1995 | WO1995004823A1 High molecular weight desulphatohirudin |
| 02/16/1995 | WO1995004822A1 Human calcium channel compositions and methods using them |
| 02/16/1995 | WO1995004821A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | WO1995004820A1 CLONING OF MAMMALIAN INWARD RECTIFIER POTASSIUM CHANNEL cDNAs |
| 02/16/1995 | WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 02/16/1995 | WO1995004814A1 Recombinant microbial fertilizer and methods for its production |
| 02/16/1995 | WO1995004756A1 Complement inhibitor proteins of non-human primates |
| 02/16/1995 | WO1995004755A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 02/16/1995 | WO1995004754A1 Antimicrobial proteins |
| 02/16/1995 | WO1995004753A1 Compositions of fusion proteins containing metallothionein and targeting-protein structural components |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004750A1 Tick derived protease inhibitor |
| 02/16/1995 | WO1995004748A1 Oligomers for modulating viral processes |
| 02/16/1995 | WO1995004744A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | WO1995004548A1 Prostatic cancer vaccine |
| 02/16/1995 | WO1995004547A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS |
| 02/16/1995 | WO1995004546A1 Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses |
| 02/16/1995 | WO1995004542A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | WO1994029472A3 Mengovirus as a vector for expression of foreign polypeptides |
| 02/16/1995 | WO1994026900A3 Hybrid picornaviruses expressing chlamydial epitopes |
| 02/16/1995 | CA2170234A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | CA2168988A1 Polypeptides coded by exon v5 of the cd44 gene as targets for immunotherapy and immunoscintigraphy of tumours |
| 02/16/1995 | CA2168952A1 Prostatic cancer vaccine |
| 02/16/1995 | CA2168582A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | CA2168448A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | CA2168437A1 Surface coating method |
| 02/16/1995 | CA2167489A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | CA2166982A1 Human calcium channel compositions and methods using them |
| 02/16/1995 | CA2166309A1 Antimicrobial proteins |